FDA Revokes Authorization of J&J’s Unpopular Covid Vaccine

June 5, 2023, 3:05 PM UTC

US regulators revoked emergency authorization for Johnson & Johnson’s Covid-19 vaccine after the company’s Janssen unit requested its withdrawal.

Janssen informed the Food and Drug Administration that shots bought by the government had expired and there was no demand for the product in the US, the regulator said in a statement released last week.

“FDA has determined that it is appropriate to protect the public health or safety to revoke this authorization,” according to the statement. The company “does not intend to update the strain composition of this vaccine to address emerging variants.”

J&J’s single-dose vaccine faced problems early ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.